| Zymeworks Inc. (ZYME) Q3 2024 Earnings Call Transcript | 10/31 22:05 | seekingalpha.com |
| Zymeworks Inc. (ZYME) Reports Q3 Loss, Lags Revenue Estimates | 10/31 18:20 | zacks.com |
| Zymeworks Announces Participation in Upcoming Investor Conferences | 10/29 06:00 | globenewswire.com |
| Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference | 10/25 06:00 | globenewswire.com |
| Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers | 10/21 06:00 | globenewswire.com |
| Zymeworks to Report Third Quarter 2024 Financial Results and Host Conference Call on October 31, 2024 | 10/10 06:30 | globenewswire.com |
| Zymeworks Approaching A Moment Of Truth With Zanidatamab | 09/27 14:47 | seekingalpha.com |
| Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference | 09/18 06:00 | globenewswire.com |
| Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c) | 09/03 16:30 | globenewswire.com |